C HAPTER 48: I MMUNOSUPPRESSANT
D RUGS
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE CHOICE
1. The nurse is monitoring a patient who is receiving m ycophenolate after an
organ transplant. Which adverse effect is possible with m ycophenolate
therapy?
a. Constipation
b. Hypertension
c. Confusion
d. Dysuria
ANS: B
Common adverse effects of m ycophenolate include hypertension,
hypotension, peripheral edema, tachycardia, chest pain and other
effects as noted in Table 48 -2. The other options are incorrect.
DIF: Cognitive Level: Appl ying (Application)
TOP: Nursing Process: Eva luation
MSC: NC LEX: Physiological Integrit y: Pharmacological and
Parenteral Therapies
2. When monitoring a patient who is on immunosuppressant therapy with
azathioprine, the nurse will monitor which laboratory results?
a. Serum potassium levels
b. White blood cell (leukocyte) count
, c. Red blood cell count
d. Serum albumin levels
ANS: B
Leukopenia is a potential adverse effect of azathioprine therapy, so
white blood cells need to be monitored. The other options are
incorrect.
DIF: Cognitive Level: Appl ying (Application)
TOP: Nursing Process: Evaluation
MSC: NC LEX: Physiological Integrit y: Reduction of Risk
Potential
3. A patient with multiple sclerosis will be starting therapy with an
immunosuppressant drug. The nurse expects that which drug will be used?
a. Azathioprine
b. Glatiramer acetate
c. Daclizumab
d. Sirolimus
ANS: B
Glatiramer acetate and fingolimod are the onl y immunosuppressants
currentl y indicated for reduction of the frequency of relapses
(exacerbations) in a type of multiple sclerosis known as relapsing -
remitting multipl e sclerosis.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Planning
MSC: NC LEX: Physiological Integrit y: Pharmacological and
Parenteral Therapies
D RUGS
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE CHOICE
1. The nurse is monitoring a patient who is receiving m ycophenolate after an
organ transplant. Which adverse effect is possible with m ycophenolate
therapy?
a. Constipation
b. Hypertension
c. Confusion
d. Dysuria
ANS: B
Common adverse effects of m ycophenolate include hypertension,
hypotension, peripheral edema, tachycardia, chest pain and other
effects as noted in Table 48 -2. The other options are incorrect.
DIF: Cognitive Level: Appl ying (Application)
TOP: Nursing Process: Eva luation
MSC: NC LEX: Physiological Integrit y: Pharmacological and
Parenteral Therapies
2. When monitoring a patient who is on immunosuppressant therapy with
azathioprine, the nurse will monitor which laboratory results?
a. Serum potassium levels
b. White blood cell (leukocyte) count
, c. Red blood cell count
d. Serum albumin levels
ANS: B
Leukopenia is a potential adverse effect of azathioprine therapy, so
white blood cells need to be monitored. The other options are
incorrect.
DIF: Cognitive Level: Appl ying (Application)
TOP: Nursing Process: Evaluation
MSC: NC LEX: Physiological Integrit y: Reduction of Risk
Potential
3. A patient with multiple sclerosis will be starting therapy with an
immunosuppressant drug. The nurse expects that which drug will be used?
a. Azathioprine
b. Glatiramer acetate
c. Daclizumab
d. Sirolimus
ANS: B
Glatiramer acetate and fingolimod are the onl y immunosuppressants
currentl y indicated for reduction of the frequency of relapses
(exacerbations) in a type of multiple sclerosis known as relapsing -
remitting multipl e sclerosis.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Planning
MSC: NC LEX: Physiological Integrit y: Pharmacological and
Parenteral Therapies
